1. Home
  2. CINF vs ILMN Comparison

CINF vs ILMN Comparison

Compare CINF & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cincinnati Financial Corporation

CINF

Cincinnati Financial Corporation

HOLD

Current Price

$165.46

Market Cap

25.2B

Sector

Finance

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.44

Market Cap

20.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINF
ILMN
Founded
1950
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.2B
20.6B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CINF
ILMN
Price
$165.46
$134.44
Analyst Decision
Strong Buy
Hold
Analyst Count
4
16
Target Price
$174.50
$117.31
AVG Volume (30 Days)
518.7K
1.6M
Earning Date
02-09-2026
02-05-2026
Dividend Yield
2.11%
N/A
EPS Growth
N/A
N/A
EPS
13.44
4.46
Revenue
$12,078,000,000.00
$4,288,000,000.00
Revenue This Year
$10.47
N/A
Revenue Next Year
N/A
$2.24
P/E Ratio
$12.26
$30.25
Revenue Growth
N/A
N/A
52 Week Low
$123.02
$68.70
52 Week High
$169.86
$153.06

Technical Indicators

Market Signals
Indicator
CINF
ILMN
Relative Strength Index (RSI) 51.06 60.74
Support Level $164.93 $132.93
Resistance Level $168.17 $138.80
Average True Range (ATR) 2.46 3.96
MACD -0.24 -0.50
Stochastic Oscillator 54.67 66.50

Price Performance

Historical Comparison
CINF
ILMN

About CINF Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, and Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: